New eye injection shows promise for diabetic retinopathy
NCT ID NCT07526857
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether faricimab injections can help people with diabetic retinopathy, a diabetes-related eye disease. Over 12 months, 60 patients received the treatment and doctors measured changes in the back of the eye. The goal was to see if the drug could reduce abnormal cells and restore protective pigments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Naples, Federico II, Napoli, Napoli
Naples, Napoli, 80127, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new eye injection preserve vision in south asians with diabetes?
- Can a One-Time gene therapy offer lasting protection for diabetic retinopathy?
- Could a biosimilar eye injection offer a new way to treat diabetic macular edema?
- Can a steroid implant boost the effect of standard eye injections for hard-to-treat diabetic macular edema?
- Can tight blood sugar control protect the eyes? a study uses advanced imaging to find out
- Could the speed of blood sugar drop harm the eyes? a study puts it to the test.